Barely Significant
← all excerpts

Octreotide in Palliative Treatment of Hepatic Metastases: Is it Effective for Clinical Stabilization?

Clin Med Oncol · 2008 · PMC3161653 · PMID 21892306

1
hedged sentence
closest p
boldest claim

The sentences

may be significantno p-value reported
The major disadvantage of octreotide use is hyperglycemia and decompensation of diabetes mellitus, which may be significant but reversible. 9 In the present, study although 71% of patients experienced hyperglycemia, this was not of clinical significance and none of the patients discontinued the therapy due to this side effect.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.